We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page.
Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site.
Observe Medical ASA has today, June 3, 2022, held the Annual General Meeting. All resolutions were made in accordance with the board's and the nomination committee's proposals. The minutes from the general meeting is attached hereto and will also be available at www.observemedical.com. For further information, please contact: Rune Nystad, CEO Observe Medical Mobile:…
Read moreOslo, 3 June 2022 – Observe Medical ASA (OSE: OBSRV) (“the Company” or “Observe Medical”) today releases its first quarter results for 2022. Observe Medical has made progress across its medtech platform during the quarter, preparing and strengthening it for growth. The Company has also streamlined the organization and other operational synergies following the acquisition…
Read moreOslo, May 13, 2022 – Observe Medical ASA (OSE:OBSRV): The annual general meeting of Observe Medical ASA will be held on Friday, June 3 2022 at 10:00 (CET). The annual general meeting will be held at Haakon VIIs gate 2, 0161 Oslo for those attending in person and via Lumi for those attending digitally. Voting…
Read moreLast updated 14 June 2022.
| Name | Number of shares | % of top 20 | % of total | Country | ||
|---|---|---|---|---|---|---|
| 1 | INGERØ REITEN INVESTMENT COMPANY AS | 9,653,680 | 26.52% | 18.05% | Norway | |
| 2 | NAVAMEDIC ASA | 4,222,727 | 11.60% | 7.89% | Norway | |
| 3 | JPB AS | 2,830,209 | 7.78% | 5.29% | Norway | |
| 4 | RO, LARS | 2,670,762 | 7.34% | 4.99% | Norway | |
| 5 | ELI AS | 2,072,086 | 5.69% | 3.87% | Norway | |
| 6 | NORDA ASA | 1,938,921 | 5.33% | 3.62% | Norway | |
| 7 | MP PENSJON PK | 1,701,188 | 4.67% | 3.18% | Norway | |
| 8 | DnB NOR Bank ASA | 1,490,225 | 4.09% | 2.79% | Norway | |
| 9 | ABN AMRO Global Custody Services | 1,441,463 | 3.96% | 2.69% | The Netherlands | |
| 10 | UBS Switzerland AG | 1,430,398 | 3.93% | 2.67% | Switzerland | |
| 11 | ALPINE CAPITAL AS | 867,434 | 2.38% | 1.62% | Norway | |
| 12 | ARTAL AS | 827,402 | 2.27% | 1.55% | Norway | |
| 13 | DnB NOR MARKETS, AKSJEHAND/ANALYSE | 825,891 | 2.27% | 1.54% | Norway | |
| 14 | LAPAS AS | 805,185 | 2.21% | 1.51% | Norway | |
| 15 | CARNEGIE AS | 794,778 | 2.18% | 1.49% | Norway | |
| 16 | NORDNET LIVSFORSIKRING AS | 665,576 | 1.83% | 1.24% | Norway | |
| 17 | SOLEGLAD INVEST AS | 586,668 | 1.61% | 1.10% | Norway | |
| 18 | SILVERCOIN INDUSTRIES AS | 574,464 | 1.58% | 1.07% | Norway | |
| 19 | TAJ HOLDING AS | 500,847 | 1.38% | 0.94% | Norway | |
| 20 | TRANBERGKOLLEN INVEST AS | 500,000 | 1.37% | 0.93% | Norway | |
| Total number owned by top 20 | 36,399,904 | 100.00% | 68.05% | |||
| Total number of shares | 53,491,656 |
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
Euronext Expand Oslo
OBSRV
4 November 2019
Healthcare
NOK
NO0010865009
19 605 457
NOK 0.26
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no
3 June 2022: Minutes from Annual General Meeting 2022
3 June 2022: Represented list
31 May 2022: Board of Directors recommendation for appointment of auditor
31 May 2022: The Nomination Committee recommendation part 2
13 May 2022: Notice of Annual General Meeting on 3 June 2022
13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022
13 May 2022: The Nomination Committee’s recommendation (part 1)
13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel
13 May 2022: Report on salary and other remuneration to executive personnel year 2021
13 May 2022: VPS – Investor services
13 May 2022: LUMI
13 May 2022: Online guide LUMI (Norsk)
13 May 2022: Online guide LUMI (English)
4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022
21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021
30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021
30 April 2021: The Nomination Committee's recommendation
30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel
30 June 2020: Annual General Meeting
16 June 2020: Extraordinary General Meeting
9 June 2020: Notice of Annual General Meeting on 30 June 2020
9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
9 June 2020: Recommendation by the Nomination Committee
9 June 2020: The Boards declaration on remuneration to executive management
26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting
Rune Nystad, Chief Executive Officer +47 91 62 46 83 / rune.nystad@observemedical.com
Per Arne Nygård, Chief Financial Officer +47 41 10 43 45 / perarne.nygard@observemedical.com